Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Jasper J.L. van Geel; Jasmine Moustaquim; Jorianne Boers; Sjoerd G. Elias; Esther M.M. Smeets; Jelijn J. Knip; Andor W.J.M. Glaudemans; Erik F.J. de Vries; Geke A.P. Hospers; Michel van Kruchten; Marcel Stokkel; Daniela E. Oprea-Lager; Willemien C. Menke-van der Houven van Oordt; Elisabeth G.E. de Vries; Carolina P. Schröder

doi:10.2967/jnumed.124.268984

Research ArticleClinical Investigation

Intrapatient 16α-[¹⁸F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Jasper J.L. van Geel, Jasmine Moustaquim, Jorianne Boers, Sjoerd G. Elias, Esther M.M. Smeets, Jelijn J. Knip, Andor W.J.M. Glaudemans, Erik F.J. de Vries, Geke A.P. Hospers, Michel van Kruchten, Marcel Stokkel, Daniela E. Oprea-Lager, Willemien C. Menke-van der Houven van Oordt, Elisabeth G.E. de Vries and Carolina P. Schröder; on behalf of the IMPACT-Metastatic Breast Consortium

Journal of Nuclear Medicine February 2025, 66 (2) 194-200; DOI: https://doi.org/10.2967/jnumed.124.268984

Jasper J.L. van Geel

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jasmine Moustaquim

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

2Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jorianne Boers

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sjoerd G. Elias

3Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Esther M.M. Smeets

3Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jelijn J. Knip

4Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands;

5Cancer Centre Amsterdam, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andor W.J.M. Glaudemans

6Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Erik F.J. de Vries

6Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Geke A.P. Hospers

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michel van Kruchten

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel Stokkel

7Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela E. Oprea-Lager

8Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands; and

9Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Willemien C. Menke-van der Houven van Oordt

4Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands;

5Cancer Centre Amsterdam, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elisabeth G.E. de Vries

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carolina P. Schröder

1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

2Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 2

February 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Intrapatient 16α-[¹⁸F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Journal of Nuclear Medicine Feb 2025, 66 (2) 194-200; DOI: 10.2967/jnumed.124.268984

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Journal of Nuclear Medicine Feb 2025, 66 (2) 194-200; DOI: 10.2967/jnumed.124.268984

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

[18F]FES PET
estrogen receptor heterogeneity
endocrine therapy
metastatic breast cancer

Main menu

User menu

Search

Intrapatient 16α-[¹⁸F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords